Suppr超能文献

完成 1 年和 2 年多药治疗(MDT)后的反应。

Reactions following completion of 1 and 2 year multidrug therapy (MDT).

机构信息

Leonard Wood Memorial Center for Leprosy Research, Cebu City, Philippines.

出版信息

Am J Trop Med Hyg. 2010 Sep;83(3):637-44. doi: 10.4269/ajtmh.2010.09-0586.

Abstract

We evaluated the incidence, severity, and duration of reactional states in 139 multibacillary (MB) leprosy patients in the first 2 years after the completion of the 1 year regimen of multidrug therapy (MDT) currently recommended by the World Health Organization (WHO) and compared those findings with 295 MB leprosy patients treated with the same regimen previously recommended for 2 years. During the first year after the completion of 1 year MDT, patients experienced 1 or more reactional states 27% of the time, the vast majority being lepra type 1 reactions (reversal reactions, RR), whereas patients who received 2 year MDT experienced a reactional state during that time period only 8% of the time (P < 0.001). Furthermore, during the first year after the completion of therapy, and during the first 2 years, both the number of reactional states and reversal reactions were significantly (P < or = 0.004) more frequent, severe, of longer duration, and more commonly associated with neuritis.

摘要

我们评估了 139 例多菌型(MB)麻风病患者在完成世卫组织(WHO)目前推荐的 1 年多药治疗(MDT)方案后的头 2 年内反应状态的发生率、严重程度和持续时间,并将这些发现与 295 例接受相同方案治疗的 MB 麻风病患者进行了比较,这些患者之前接受了 2 年的治疗。在完成 1 年 MDT 后的第一年,患者有 1 次或多次反应状态的时间占 27%,绝大多数是麻风 1 型反应(逆转反应,RR),而接受 2 年 MDT 的患者在那段时间只有 8%的时间(P < 0.001)发生反应状态。此外,在治疗完成后的第一年和前两年,反应状态和逆转反应的数量、严重程度、持续时间以及更常与神经炎相关的情况都明显(P < or = 0.004)更为频繁。

相似文献

1
Reactions following completion of 1 and 2 year multidrug therapy (MDT).
Am J Trop Med Hyg. 2010 Sep;83(3):637-44. doi: 10.4269/ajtmh.2010.09-0586.
3
Daily multidrug therapy for leprosy; results of a fourteen-year experience.
Int J Lepr Other Mycobact Dis. 1997 Mar;65(1):37-44.
5
[Leprosy reactions in discharged patients following cure by multidrug therapy].
Rev Soc Bras Med Trop. 2010 Nov-Dec;43(6):737-9. doi: 10.1590/s0037-86822010000600029.
6
Effectiveness of MDT in multibacillary leprosy.
Int J Lepr Other Mycobact Dis. 1996 Jun;64(2):128-32.

引用本文的文献

1
Exploring the experiences of leprosy stigma among patients and healthcare workers in Norte de Santander, Colombia.
PLOS Glob Public Health. 2025 Mar 18;5(3):e0003939. doi: 10.1371/journal.pgph.0003939. eCollection 2025.
2
Healthcare performance of leprosy management in peripheral health facilities of Dhanusa and Mahottari, Nepal.
BMC Health Serv Res. 2025 Jan 30;25(1):177. doi: 10.1186/s12913-025-12334-3.
3
Hypogonadism and associated factors among male Leprosy patients.
PLoS Negl Trop Dis. 2024 Aug 5;18(8):e0012374. doi: 10.1371/journal.pntd.0012374. eCollection 2024 Aug.
4
Clinical, epidemiological, and laboratory prognostic factors in patients with leprosy reactions: A 10-year retrospective cohort study.
Front Med (Lausanne). 2022 Jul 25;9:841030. doi: 10.3389/fmed.2022.841030. eCollection 2022.
5
Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management.
J Trop Med. 2022 Jul 4;2022:8652062. doi: 10.1155/2022/8652062. eCollection 2022.
8
The DermLep Study I: Results of Prospective Nation-Wide Survey of the Number & Profile of Leprosy Patients seen by Dermatologists in India.
Indian Dermatol Online J. 2020 Sep 19;11(5):701-711. doi: 10.4103/idoj.IDOJ_466_20. eCollection 2020 Sep-Oct.
9
What is New in the Pathogenesis and Management of Erythema Nodosum Leprosum.
Indian Dermatol Online J. 2020 Jul 13;11(4):482-492. doi: 10.4103/idoj.IDOJ_561_19. eCollection 2020 Jul-Aug.
10
Diagnosis and impact of neuropathic pain in leprosy patients in Nepal after completion of multidrug therapy.
PLoS Negl Trop Dis. 2018 Jul 2;12(7):e0006610. doi: 10.1371/journal.pntd.0006610. eCollection 2018 Jul.

本文引用的文献

1
The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low.
Int J Lepr Other Mycobact Dis. 2004 Dec;72(4):493-500. doi: 10.1489/1544-581X(2004)72<493:TRRIML>2.0.CO;2.
2
Epidemiological characteristics of leprosy reactions: 15 years experience from north India.
Int J Lepr Other Mycobact Dis. 2004 Jun;72(2):125-33. doi: 10.1489/1544-581X(2004)072<0125:ECOLRY>2.0.CO;2.
3
Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
Int J Lepr Other Mycobact Dis. 2003 Dec;71(4):308-19. doi: 10.1489/1544-581X(2003)071<0308:LEOYWM>2.0.CO;2.
7
Reversal reactions in the skin lesions of AMFES patients: incidence and risk factors.
Lepr Rev. 2000 Sep;71(3):309-17. doi: 10.5935/0305-7518.20000034.
8
Relapses in multibacillary leprosy patients: effect of length of therapy.
Lepr Rev. 2000 Jun;71(2):144-53. doi: 10.5935/0305-7518.20000017.
9
Pregnancy and leprosy: a comprehensive literature review.
Int J Lepr Other Mycobact Dis. 1999 Mar;67(1):6-12.
10
The management of leprosy reversal reactions.
Lepr Rev. 1998 Sep;69(3):225-34. doi: 10.5935/0305-7518.19980024.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验